PDB Short entry for 5UNF HEADER SIGNALING PROTEIN 30-JAN-17 5UNF TITLE XFEL STRUCTURE OF HUMAN ANGIOTENSIN II TYPE 2 RECEPTOR (MONOCLINIC TITLE 2 FORM) IN COMPLEX WITH COMPOUND 1 (N-BENZYL-N-(2-ETHYL-4-OXO-3-{[2'- TITLE 3 (2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHIMERA PROTEIN OF TYPE-2 ANGIOTENSIN II RECEPTOR AND COMPND 3 SOLUBLE CYTOCHROME B562; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: UNP P0ABE7 RESIDUES 23-128 AND UNP P50052 35-335 LINKED VIA COMPND 6 LINKER RESDIUES GSGS; COMPND 7 SYNONYM: CYTOCHROME B-562,ANGIOTENSIN II TYPE-2 RECEPTOR,AT2; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 562, 9606; SOURCE 5 GENE: CYBC, AGTR2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS HUMAN ANGIOTENSIN II RECEPTOR COMPLEX, GPCR SIGNALING, GPCR, BRIL, KEYWDS 2 MEMBRANE PROTEIN, LCP, XFEL, BLOOD PRESSURE REGULATION, MONOCLINIC KEYWDS 3 CRYSTAL, COMPOUND 1 (CPD 1), SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.ZHANG,G.W.HAN,A.BATYUK,A.ISHCHENKO,K.L.WHITE,N.PATEL,A.SADYBEKOV, AUTHOR 2 B.ZAMLYNNY,M.T.RUDD,K.HOLLENSTEIN,A.TOLSTIKOVA,T.A.WHITE,M.S.HUNTER, AUTHOR 3 U.WEIERSTALL,W.LIU,K.BABAOGLU,E.L.MOORE,R.D.KATZ,J.M.SHIPMAN, AUTHOR 4 M.GARCIA-CALVO,S.SHARMA,P.SHETH,S.M.SOISSON,R.C.STEVENS,V.KATRITCH, AUTHOR 5 V.CHEREZOV REVDAT 4 04-OCT-23 5UNF 1 REMARK REVDAT 3 28-NOV-18 5UNF 1 REMARK REVDAT 2 10-MAY-17 5UNF 1 JRNL REMARK REVDAT 1 05-APR-17 5UNF 0 JRNL AUTH H.ZHANG,G.W.HAN,A.BATYUK,A.ISHCHENKO,K.L.WHITE,N.PATEL, JRNL AUTH 2 A.SADYBEKOV,B.ZAMLYNNY,M.T.RUDD,K.HOLLENSTEIN,A.TOLSTIKOVA, JRNL AUTH 3 T.A.WHITE,M.S.HUNTER,U.WEIERSTALL,W.LIU,K.BABAOGLU, JRNL AUTH 4 E.L.MOORE,R.D.KATZ,J.M.SHIPMAN,M.GARCIA-CALVO,S.SHARMA, JRNL AUTH 5 P.SHETH,S.M.SOISSON,R.C.STEVENS,V.KATRITCH,V.CHEREZOV JRNL TITL STRUCTURAL BASIS FOR SELECTIVITY AND DIVERSITY IN JRNL TITL 2 ANGIOTENSIN II RECEPTORS. JRNL REF NATURE V. 544 327 2017 JRNL REFN ESSN 1476-4687 JRNL PMID 28379944 JRNL DOI 10.1038/NATURE22035 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 22906 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 1118 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.92 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.78 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2762 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2250 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2613 REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE : 0.2490 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.39 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 149 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6151 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 92 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 90.78 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 111.9 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.10360 REMARK 3 B22 (A**2) : -10.18020 REMARK 3 B33 (A**2) : 3.07660 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.58750 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.480 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.359 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.900 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : 8739 ; 2.500 ; HARMONIC REMARK 3 TORSION ANGLES : 2836 ; 15.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 117 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 925 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6414 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 850 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7691 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : 0.90 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.54 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 1.53 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A| 1001 - 1100 } REMARK 3 ORIGIN FOR THE GROUP (A): 102.5845 19.7753 41.6970 REMARK 3 T TENSOR REMARK 3 T11: -0.1920 T22: 0.0445 REMARK 3 T33: -0.1112 T12: -0.0324 REMARK 3 T13: -0.0325 T23: 0.0221 REMARK 3 L TENSOR REMARK 3 L11: 4.8239 L22: 4.0630 REMARK 3 L33: 6.3458 L12: 0.4122 REMARK 3 L13: -3.7327 L23: -2.0703 REMARK 3 S TENSOR REMARK 3 S11: 0.1144 S12: -0.2944 S13: -0.2836 REMARK 3 S21: 0.2874 S22: -0.1144 S23: 0.2193 REMARK 3 S31: -0.0306 S32: -0.0615 S33: 0.0000 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A| 43 - 334 } REMARK 3 ORIGIN FOR THE GROUP (A): 68.9021 -1.9496 34.3486 REMARK 3 T TENSOR REMARK 3 T11: -0.3372 T22: 0.3040 REMARK 3 T33: -0.2707 T12: 0.1096 REMARK 3 T13: 0.0609 T23: 0.1849 REMARK 3 L TENSOR REMARK 3 L11: 0.6346 L22: 2.2799 REMARK 3 L33: 2.8729 L12: -1.3278 REMARK 3 L13: -0.5126 L23: -0.2802 REMARK 3 S TENSOR REMARK 3 S11: -0.2198 S12: -0.6620 S13: -0.2399 REMARK 3 S21: 0.4053 S22: 0.3253 S23: 0.4066 REMARK 3 S31: 0.2141 S32: 0.3926 S33: -0.1055 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { B| 1001 - 1110 } REMARK 3 ORIGIN FOR THE GROUP (A): 38.7976 30.9461 4.3458 REMARK 3 T TENSOR REMARK 3 T11: -0.3009 T22: -0.2209 REMARK 3 T33: 0.0676 T12: -0.0056 REMARK 3 T13: -0.0345 T23: -0.0127 REMARK 3 L TENSOR REMARK 3 L11: 9.2243 L22: 5.7082 REMARK 3 L33: 7.4066 L12: -1.7595 REMARK 3 L13: -1.6628 L23: -1.1169 REMARK 3 S TENSOR REMARK 3 S11: 0.0113 S12: -0.0034 S13: -0.0337 REMARK 3 S21: -0.2532 S22: 0.0186 S23: -0.3855 REMARK 3 S31: 0.0050 S32: 0.0802 S33: -0.0299 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { B| 35 - 334 } REMARK 3 ORIGIN FOR THE GROUP (A): 75.0278 11.9359 6.0131 REMARK 3 T TENSOR REMARK 3 T11: -0.2139 T22: -0.2136 REMARK 3 T33: 0.0190 T12: -0.0067 REMARK 3 T13: -0.0348 T23: -0.0139 REMARK 3 L TENSOR REMARK 3 L11: 2.2431 L22: 2.0458 REMARK 3 L33: 1.3565 L12: -0.8457 REMARK 3 L13: -0.3922 L23: -0.2856 REMARK 3 S TENSOR REMARK 3 S11: -0.0445 S12: -0.2517 S13: 0.1585 REMARK 3 S21: 0.0737 S22: 0.1000 S23: -0.1267 REMARK 3 S31: 0.0473 S32: 0.0532 S33: -0.0555 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UNF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1000226050. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 294 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : FREE ELECTRON LASER REMARK 200 BEAMLINE : CXI REMARK 200 X-RAY GENERATOR MODEL : SLAC LCLS BEAMLINE CXI REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.3 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : K-B MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : CS-PAD CXI-1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTFEL REMARK 200 DATA SCALING SOFTWARE : CRYSTFEL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22934 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 61.60 REMARK 200 R MERGE (I) : 0.16400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 61.60 REMARK 200 R MERGE FOR SHELL (I) : 1.72000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4YAY, 4ZUD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS-HCL, PH 8.0, 25 MM REMARK 280 POTASSIUM FORMATE, 25% (V/V) PEG400, AND 0.3% (V/V) (+/-)-2- REMARK 280 METHYL-2,4-PENTANEDIOL, LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.55500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE BIOLOGICAL UNIT IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 37220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 1101 REMARK 465 ILE A 1102 REMARK 465 GLN A 1103 REMARK 465 LYS A 1104 REMARK 465 TYR A 1105 REMARK 465 LEU A 1106 REMARK 465 GLY A 1107 REMARK 465 SER A 1108 REMARK 465 GLY A 1109 REMARK 465 SER A 1110 REMARK 465 CYS A 35 REMARK 465 SER A 36 REMARK 465 GLN A 37 REMARK 465 LYS A 38 REMARK 465 PRO A 39 REMARK 465 SER A 40 REMARK 465 ASP A 41 REMARK 465 LYS A 42 REMARK 465 LEU A 151 REMARK 465 SER A 152 REMARK 465 GLN A 153 REMARK 465 ARG A 154 REMARK 465 ARG A 155 REMARK 465 ASN A 156 REMARK 465 VAL A 335 REMARK 465 LYS B 73 REMARK 465 GLY B 74 REMARK 465 PRO B 75 REMARK 465 LYS B 76 REMARK 465 LEU B 151 REMARK 465 SER B 152 REMARK 465 GLN B 153 REMARK 465 ARG B 154 REMARK 465 ARG B 155 REMARK 465 ASN B 156 REMARK 465 PRO B 157 REMARK 465 VAL B 335 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1042 CE NZ REMARK 470 ARG A 107 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 188 CG CD OE1 OE2 REMARK 470 LYS A 203 CG CD CE NZ REMARK 470 THR A 241 OG1 CG2 REMARK 470 SER A 243 OG REMARK 470 SER A 289 OG REMARK 470 LEU A 300 CG CD1 CD2 REMARK 470 ARG A 330 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 333 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 334 CG CD NE CZ NH1 NH2 REMARK 470 LYS B1042 CE NZ REMARK 470 LEU B1048 CG CD1 CD2 REMARK 470 ASP B1050 CG OD1 OD2 REMARK 470 LEU B1106 CG CD1 CD2 REMARK 470 SER B 36 OG REMARK 470 GLN B 37 CG CD OE1 NE2 REMARK 470 LYS B 38 CG CD CE NZ REMARK 470 PHE B 150 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 188 CG CD OE1 OE2 REMARK 470 LYS B 240 NZ REMARK 470 LYS B 246 CG CD CE NZ REMARK 470 ASN B 247 CG OD1 ND2 REMARK 470 GLN B 326 CG CD OE1 NE2 REMARK 470 ARG B 330 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 333 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 334 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 70 -75.46 -86.47 REMARK 500 LYS A 73 -85.62 -148.13 REMARK 500 LYS A 77 156.45 71.13 REMARK 500 ALA A 198 78.12 -65.15 REMARK 500 PHE A 220 -59.83 -140.22 REMARK 500 TYR A 244 -29.30 -151.02 REMARK 500 TYR A 318 -46.66 -130.72 REMARK 500 LYS B1104 -69.94 -125.27 REMARK 500 SER B1108 24.52 -78.74 REMARK 500 SER B1110 68.95 -102.35 REMARK 500 CYS B 35 -83.14 -164.66 REMARK 500 PHE B 220 -59.62 -139.91 REMARK 500 THR B 241 -73.77 -114.79 REMARK 500 VAL B 321 -34.42 -133.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8ES A 1501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8ES B 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5UNG RELATED DB: PDB REMARK 900 RELATED ID: 5UNH RELATED DB: PDB DBREF 5UNF A 1001 1106 UNP P0ABE7 C562_ECOLX 23 128 DBREF 5UNF A 35 335 UNP P50052 AGTR2_HUMAN 35 335 DBREF 5UNF B 1001 1106 UNP P0ABE7 C562_ECOLX 23 128 DBREF 5UNF B 35 335 UNP P50052 AGTR2_HUMAN 35 335 SEQADV 5UNF TRP A 1007 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 5UNF ILE A 1102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 5UNF LEU A 1106 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQADV 5UNF GLY A 1107 UNP P0ABE7 LINKER SEQADV 5UNF SER A 1108 UNP P0ABE7 LINKER SEQADV 5UNF GLY A 1109 UNP P0ABE7 LINKER SEQADV 5UNF SER A 1110 UNP P0ABE7 LINKER SEQADV 5UNF TRP B 1007 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 5UNF ILE B 1102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 5UNF LEU B 1106 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQADV 5UNF GLY B 1107 UNP P0ABE7 LINKER SEQADV 5UNF SER B 1108 UNP P0ABE7 LINKER SEQADV 5UNF GLY B 1109 UNP P0ABE7 LINKER SEQADV 5UNF SER B 1110 UNP P0ABE7 LINKER SEQRES 1 A 411 ALA ASP LEU GLU ASP ASN TRP GLU THR LEU ASN ASP ASN SEQRES 2 A 411 LEU LYS VAL ILE GLU LYS ALA ASP ASN ALA ALA GLN VAL SEQRES 3 A 411 LYS ASP ALA LEU THR LYS MET ARG ALA ALA ALA LEU ASP SEQRES 4 A 411 ALA GLN LYS ALA THR PRO PRO LYS LEU GLU ASP LYS SER SEQRES 5 A 411 PRO ASP SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE SEQRES 6 A 411 ASP ILE LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU SEQRES 7 A 411 ALA ASN GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA SEQRES 8 A 411 GLU GLN LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS SEQRES 9 A 411 TYR LEU GLY SER GLY SER CYS SER GLN LYS PRO SER ASP SEQRES 10 A 411 LYS HIS LEU ASP ALA ILE PRO ILE LEU TYR TYR ILE ILE SEQRES 11 A 411 PHE VAL ILE GLY PHE LEU VAL ASN ILE VAL VAL VAL THR SEQRES 12 A 411 LEU PHE CYS CYS GLN LYS GLY PRO LYS LYS VAL SER SER SEQRES 13 A 411 ILE TYR ILE PHE ASN LEU ALA VAL ALA ASP LEU LEU LEU SEQRES 14 A 411 LEU ALA THR LEU PRO LEU TRP ALA THR TYR TYR SER TYR SEQRES 15 A 411 ARG TYR ASP TRP LEU PHE GLY PRO VAL MET CYS LYS VAL SEQRES 16 A 411 PHE GLY SER PHE LEU THR LEU ASN MET PHE ALA SER ILE SEQRES 17 A 411 PHE PHE ILE THR CYS MET SER VAL ASP ARG TYR GLN SER SEQRES 18 A 411 VAL ILE TYR PRO PHE LEU SER GLN ARG ARG ASN PRO TRP SEQRES 19 A 411 GLN ALA SER TYR ILE VAL PRO LEU VAL TRP CYS MET ALA SEQRES 20 A 411 CYS LEU SER SER LEU PRO THR PHE TYR PHE ARG ASP VAL SEQRES 21 A 411 ARG THR ILE GLU TYR LEU GLY VAL ASN ALA CYS ILE MET SEQRES 22 A 411 ALA PHE PRO PRO GLU LYS TYR ALA GLN TRP SER ALA GLY SEQRES 23 A 411 ILE ALA LEU MET LYS ASN ILE LEU GLY PHE ILE ILE PRO SEQRES 24 A 411 LEU ILE PHE ILE ALA THR CYS TYR PHE GLY ILE ARG LYS SEQRES 25 A 411 HIS LEU LEU LYS THR ASN SER TYR GLY LYS ASN ARG ILE SEQRES 26 A 411 THR ARG ASP GLN VAL LEU LYS MET ALA ALA ALA VAL VAL SEQRES 27 A 411 LEU ALA PHE ILE ILE CYS TRP LEU PRO PHE HIS VAL LEU SEQRES 28 A 411 THR PHE LEU ASP ALA LEU ALA TRP MET GLY VAL ILE ASN SEQRES 29 A 411 SER CYS GLU VAL ILE ALA VAL ILE ASP LEU ALA LEU PRO SEQRES 30 A 411 PHE ALA ILE LEU LEU GLY PHE THR ASN SER CYS VAL ASN SEQRES 31 A 411 PRO PHE LEU TYR CYS PHE VAL GLY ASN ARG PHE GLN GLN SEQRES 32 A 411 LYS LEU ARG SER VAL PHE ARG VAL SEQRES 1 B 411 ALA ASP LEU GLU ASP ASN TRP GLU THR LEU ASN ASP ASN SEQRES 2 B 411 LEU LYS VAL ILE GLU LYS ALA ASP ASN ALA ALA GLN VAL SEQRES 3 B 411 LYS ASP ALA LEU THR LYS MET ARG ALA ALA ALA LEU ASP SEQRES 4 B 411 ALA GLN LYS ALA THR PRO PRO LYS LEU GLU ASP LYS SER SEQRES 5 B 411 PRO ASP SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE SEQRES 6 B 411 ASP ILE LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU SEQRES 7 B 411 ALA ASN GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA SEQRES 8 B 411 GLU GLN LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS SEQRES 9 B 411 TYR LEU GLY SER GLY SER CYS SER GLN LYS PRO SER ASP SEQRES 10 B 411 LYS HIS LEU ASP ALA ILE PRO ILE LEU TYR TYR ILE ILE SEQRES 11 B 411 PHE VAL ILE GLY PHE LEU VAL ASN ILE VAL VAL VAL THR SEQRES 12 B 411 LEU PHE CYS CYS GLN LYS GLY PRO LYS LYS VAL SER SER SEQRES 13 B 411 ILE TYR ILE PHE ASN LEU ALA VAL ALA ASP LEU LEU LEU SEQRES 14 B 411 LEU ALA THR LEU PRO LEU TRP ALA THR TYR TYR SER TYR SEQRES 15 B 411 ARG TYR ASP TRP LEU PHE GLY PRO VAL MET CYS LYS VAL SEQRES 16 B 411 PHE GLY SER PHE LEU THR LEU ASN MET PHE ALA SER ILE SEQRES 17 B 411 PHE PHE ILE THR CYS MET SER VAL ASP ARG TYR GLN SER SEQRES 18 B 411 VAL ILE TYR PRO PHE LEU SER GLN ARG ARG ASN PRO TRP SEQRES 19 B 411 GLN ALA SER TYR ILE VAL PRO LEU VAL TRP CYS MET ALA SEQRES 20 B 411 CYS LEU SER SER LEU PRO THR PHE TYR PHE ARG ASP VAL SEQRES 21 B 411 ARG THR ILE GLU TYR LEU GLY VAL ASN ALA CYS ILE MET SEQRES 22 B 411 ALA PHE PRO PRO GLU LYS TYR ALA GLN TRP SER ALA GLY SEQRES 23 B 411 ILE ALA LEU MET LYS ASN ILE LEU GLY PHE ILE ILE PRO SEQRES 24 B 411 LEU ILE PHE ILE ALA THR CYS TYR PHE GLY ILE ARG LYS SEQRES 25 B 411 HIS LEU LEU LYS THR ASN SER TYR GLY LYS ASN ARG ILE SEQRES 26 B 411 THR ARG ASP GLN VAL LEU LYS MET ALA ALA ALA VAL VAL SEQRES 27 B 411 LEU ALA PHE ILE ILE CYS TRP LEU PRO PHE HIS VAL LEU SEQRES 28 B 411 THR PHE LEU ASP ALA LEU ALA TRP MET GLY VAL ILE ASN SEQRES 29 B 411 SER CYS GLU VAL ILE ALA VAL ILE ASP LEU ALA LEU PRO SEQRES 30 B 411 PHE ALA ILE LEU LEU GLY PHE THR ASN SER CYS VAL ASN SEQRES 31 B 411 PRO PHE LEU TYR CYS PHE VAL GLY ASN ARG PHE GLN GLN SEQRES 32 B 411 LYS LEU ARG SER VAL PHE ARG VAL HET 8ES A1501 46 HET 8ES B1201 46 HETNAM 8ES N-BENZYL-N-(2-ETHYL-4-OXO-3-{[2'-(2H-TETRAZOL-5-YL)[1, HETNAM 2 8ES 1'-BIPHENYL]-4-YL]METHYL}-3,4-DIHYDROQUINAZOLIN-6-YL) HETNAM 3 8ES THIOPHENE-2-CARBOXAMIDE FORMUL 3 8ES 2(C36 H29 N7 O2 S) HELIX 1 AA1 ASP A 1002 LYS A 1019 1 18 HELIX 2 AA2 ASN A 1022 ALA A 1043 1 22 HELIX 3 AA3 SER A 1055 GLY A 1082 1 28 HELIX 4 AA4 LYS A 1083 GLU A 1092 1 10 HELIX 5 AA5 GLU A 1092 ALA A 1100 1 9 HELIX 6 AA6 ASP A 45 GLN A 72 1 28 HELIX 7 AA7 VAL A 78 ALA A 95 1 18 HELIX 8 AA8 THR A 96 TYR A 106 1 11 HELIX 9 AA9 PHE A 112 TYR A 148 1 37 HELIX 10 AB1 TRP A 158 SER A 175 1 18 HELIX 11 AB2 SER A 175 PHE A 181 1 7 HELIX 12 AB3 PRO A 200 LYS A 203 5 4 HELIX 13 AB4 TYR A 204 PHE A 220 1 17 HELIX 14 AB5 PHE A 220 THR A 241 1 22 HELIX 15 AB6 GLY A 245 MET A 284 1 40 HELIX 16 AB7 SER A 289 CYS A 319 1 31 HELIX 17 AB8 VAL A 321 ARG A 334 1 14 HELIX 18 AB9 ASP B 1002 LYS B 1019 1 18 HELIX 19 AC1 ASN B 1022 ALA B 1043 1 22 HELIX 20 AC2 SER B 1055 GLY B 1082 1 28 HELIX 21 AC3 LYS B 1083 ALA B 1091 1 9 HELIX 22 AC4 GLU B 1092 GLN B 1103 1 12 HELIX 23 AC5 GLY B 1107 CYS B 35 5 5 HELIX 24 AC6 ASP B 45 GLN B 72 1 28 HELIX 25 AC7 VAL B 78 ALA B 95 1 18 HELIX 26 AC8 THR B 96 TYR B 106 1 11 HELIX 27 AC9 PHE B 112 TYR B 148 1 37 HELIX 28 AD1 GLN B 159 SER B 175 1 17 HELIX 29 AD2 SER B 175 PHE B 181 1 7 HELIX 30 AD3 PRO B 200 GLU B 202 5 3 HELIX 31 AD4 LYS B 203 PHE B 220 1 18 HELIX 32 AD5 PHE B 220 LEU B 239 1 20 HELIX 33 AD6 GLY B 245 MET B 284 1 40 HELIX 34 AD7 SER B 289 TYR B 318 1 30 HELIX 35 AD8 TYR B 318 ARG B 334 1 17 SHEET 1 AA1 2 ARG A 182 THR A 186 0 SHEET 2 AA1 2 ASN A 193 MET A 197 -1 O ALA A 194 N ARG A 185 SHEET 1 AA2 2 ARG B 182 THR B 186 0 SHEET 2 AA2 2 ASN B 193 MET B 197 -1 O ILE B 196 N ASP B 183 SSBOND 1 CYS A 117 CYS A 195 1555 1555 2.03 SSBOND 2 CYS B 35 CYS B 290 1555 1555 2.03 SSBOND 3 CYS B 117 CYS B 195 1555 1555 2.03 SITE 1 AC1 16 TYR A 51 TRP A 100 TYR A 103 TYR A 108 SITE 2 AC1 16 LEU A 124 THR A 125 MET A 128 PHE A 129 SITE 3 AC1 16 THR A 178 ARG A 182 MET A 214 LYS A 215 SITE 4 AC1 16 TRP A 269 PHE A 272 ILE A 304 PHE A 308 SITE 1 AC2 15 TYR B 51 TRP B 100 TYR B 103 TYR B 108 SITE 2 AC2 15 LEU B 124 THR B 125 MET B 128 PHE B 129 SITE 3 AC2 15 THR B 178 ARG B 182 LYS B 215 TRP B 269 SITE 4 AC2 15 PHE B 272 ILE B 304 PHE B 308 CRYST1 77.390 69.110 90.070 90.00 104.33 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012922 0.000000 0.003301 0.00000 SCALE2 0.000000 0.014470 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011459 0.00000